I testified last week before the FDA Advisory Committee on lorcaserin about obesity and cancer. Here are my prepared remarks. More
Posted in DAILY DOWNEY, Featured
You can follow any responses to this entry through the RSS 2.0 Feed. You can skip to the end and leave a response. Pinging is currently not allowed.
adolescents AHRQ Arena Pharmaceuticals Barack Obama Bariatric Surgery BMI breast cancer cancer cardiovascular disease CDC Childhood Obesity children Contrave costs David Ludwig diabetes disability disease Environment FDA food Food and Drug Administration genetics health care reform hypertension Institute of Medicine leptin Look Ahead lorcaserin Medicaid Medicare Michelle Obama mortality NIH Orexigen overweight Physical Activity prevalence Prevention Qnexa smoking Surgeon General Type 2 diabetes USDA Vivus Inc
WP Cumulus Flash tag cloud by Roy Tanck requires Flash Player 9 or better.
ADVERTISEMENTS
© 2012 The Downey Obesity Report · Terms of Service · Contact · Proudly powered by WordPress